Protection in just 1 dose.
Just one dose of Prevnar 20® helps protect against 20 strains of the bacteria that cause pneumococcal pneumonia—which can strike anytime, anywhere.
Compared to Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), Prevnar 20 helps protect against:
Prevnar 20 won’t give you pneumococcal pneumonia.
That’s because Prevnar 20 does not contain live bacteria.
Prevnar 20 is designed to protect against pneumococcal pneumonia and invasive pneumococcal disease.
There are 2 types of pneumococcal vaccines—polysaccharides and conjugates. Prevnar 20 is a conjugate vaccine. Conjugate vaccines work by combining proteins with small pieces of inactive pneumococcal bacteria to help activate the immune system. Your body is able to recognize the bacteria without getting you sick. This process helps your immune system make antibodies that can help protect you from 20 strains of the bacteria that cause pneumococcal pneumonia and invasive pneumococcal disease, like meningitis or blood infection.
Is Prevnar 20 right for me?
You may already be doing a lot to protect your health, and here's a way to do even more.
If you’re 50 or older, or 19 or older with certain chronic conditions, you may be at greater risk for pneumococcal pneumonia—even if you feel healthy. Talk to your doctor or pharmacist to better understand your risk and ask if Prevnar 20 is right for you.
Prevnar 20 was studied in adults with chronic conditions including diabetes, kidney disorders, lung disease, liver disease, and heart disease.
What if I’ve previously received another pneumonia vaccine?
If you've already been vaccinated with another pneumococcal vaccine like PCV13 or PCV15, ask your doctor or pharmacist if you are eligible for Prevnar 20.
PCV13=13-valent pneumococcal conjugate vaccine; PCV15=15-valent pneumococcal conjugate vaccine.
Prevnar* vaccines have a demonstrated safety profile and have been given to approximately 75 million† adults in the US over 10 years.
*Prevnar vaccines include Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) and Prevnar 20. In the US, Prevnar 13 was available for adults from 2012 to 2024.
†Based on information licensed from IQVIA: Longitudinal prescription and medical claims data from January 2014 to March 2025, reflecting estimates of real-world activity. IQVIA® is a registered trademark of IQVIA Inc. All rights reserved.